Filing Details

Accession Number:
0001628280-19-004409
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-04-17 20:50:44
Reporting Period:
2019-04-15
Accepted Time:
2019-04-17 20:50:44
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1576280 Guardant Health Inc. GH Services-Medical Laboratories (8071) 454139254
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1721003 B. Richard Lanman 505 Penobscot Drive
Redwood City CA 94063
Chief Medical Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-04-15 45,000 $1.43 175,631 No 4 M Direct
Common Stock Disposition 2019-04-15 31,500 $73.98 144,131 No 4 S Direct
Common Stock Disposition 2019-04-15 13,500 $76.05 130,631 No 4 S Direct
Common Stock Acquisiton 2019-04-16 45,000 $1.43 175,631 No 4 M Direct
Common Stock Disposition 2019-04-16 45,000 $76.56 130,631 No 4 S Direct
Common Stock Acquisiton 2019-04-17 21,652 $1.43 152,283 No 4 M Direct
Common Stock Acquisiton 2019-04-17 17,676 $4.18 169,959 No 4 M Direct
Common Stock Acquisiton 2019-04-17 6,916 $8.80 176,875 No 4 M Direct
Common Stock Disposition 2019-04-17 27,396 $71.66 149,479 No 4 S Direct
Common Stock Disposition 2019-04-17 18,848 $72.98 130,631 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock STOCK OPTION (RIGHT TO BUY) Disposition 2019-04-15 45,000 $0.00 45,000 $1.43
Common Stock STOCK OPTION (RIGHT TO BUY) Disposition 2019-04-16 45,000 $0.00 45,000 $1.43
Common Stock STOCK OPTION (RIGHT TO BUY) Disposition 2019-04-17 21,652 $0.00 21,652 $1.43
Common Stock STOCK OPTION (RIGHT TO BUY) Disposition 2019-04-17 17,676 $0.00 17,676 $4.18
Common Stock STOCK OPTION (RIGHT TO BUY) Disposition 2019-04-17 6,916 $0.00 6,916 $8.80
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
106,331 2024-10-16 No 4 M Direct
61,331 2024-10-16 No 4 M Direct
39,679 2024-10-16 No 4 M Direct
19,214 2027-04-30 No 4 M Direct
48,419 2028-08-21 No 4 M Direct
Footnotes
  1. These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. The shares sold were acquired contemporaneously upon the cashless exercise of one or more stock options at an exercise price of $1.43, $4.18 or $8.80 per share.
  2. The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $73.86 to $74.19. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected.
  3. The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $75.92 to $76.29. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected.
  4. The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $76.44 to $76.64. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected.
  5. The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $71.50 to $71.76. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected.
  6. The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $72.92 to $73.86. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected.
  7. The exercise price of $1.42 reported in the Reporting Person's Form 3 filed on October 3, 2018 was in error.
  8. The stock option vests and becomes exercisable as to 25% of the option on September 2, 2015, thereafter vests in equal monthly installments over 36 months.
  9. The exercise price of $4.17 reported in the Reporting Person's Form 3 filed on October 3, 2018 was in error.
  10. The stock option vests and becomes exercisable in equal monthly installments over 48 months commencing on April 1, 2017.
  11. The stock option vests and becomes exercisable in equal monthly installments over 48 months commencing on August 22, 2018